Histopathological Changes in Gastrointestinal Tissues of Wistar Rats administered with Methanolic Leaf Extract of Caladium bicolor (Araceae)
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
European Journal of Medicinal Plants
Abstract
To  assess  the  effect  of  methanolic  leaf  extract  of  Caladium  bicolor  on  the  histomorphology  of gastrointestinal tissues of experimental animals. Twenty  four  Wistar  rats  (weighing  between  175-190  g)  were  randomly  and  equally  divided  into  four groups  which  include  one  control  group  (CG)  and  three  treatment  groups  (TG  I,  TG  II  and  TG  III). The  CG  was  administered  with  distilled  water  [2  ml/kg  body  weight  (b.w.)]  while  TGs  I,  II  and  III were  administered  with  100  ml/kg,  200  ml/kg and  300  ml/kg  (b.w.) of  C.  bicolor  extract respectively. All  administrations  were  done  orally  and  once  daily  for  a  period  of  thirty  days.  The  body  weight  of all  animals  was  recorded  at  the  beginning  and  end  of  study.  After  the  period  of  study,  gastric  and small  intestinal  tissues  of  experimental  animals  were  harvested,  processed,  converted  to  tissue blocks  and  sectioned.  Tissue  sections  were  stained  using  Haematoxylin  and  Eosin  (H&E) technique.  Thereafter,  stained  sections  microscopically  examined  for  observable  histopathological changes  within  study  tissues. The  results  of  this  study  showed  that  exposure  to  C.  bicolor  extract  causes  significant  (p  <  0.05) body  weight  loss  in  TGs  I-III  compared  to  CG.  In  addition,  prominent  histopathological  changes were  observed  in  gastrointestinal  tissues  of  experimental  animals  in  TGs  I-III  including  gastric mucosal  surface  erosion  and  intestinal  villi  degeneration  compared  to  normal  gastrointestinal histomorphology  of  CG  animals. These  histopathological  changes  may  be  associated  with  toxic  effect  of  phytochemicals constituents  of  the  extract.  Therefore,  its  application  for  therapeutic  purposes  needs  to  be thoroughly  re-validated  or  perhaps  disallowed  where  alternative  therapeutic  agents  with  minimal toxic  potential  exist.
